SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is capturing attention as community members rally behind its organic growth strategy, actively avoiding the typical pump-and-dump cycles associated with other meme tokens. Investors are showing strong conviction in the project's long-term potential, frequently discussing its lack of a chart as a badge of early-stage authenticity while pushing for increased volume to drive the next leg of upward momentum.

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

ICU Medical, Inc.

ICU Medical is trending as investors evaluate its integration of recent acquisitions and the company's long-term growth potential in the infusion systems and medical device market. The community remains focused on technical turnaround potential, management performance, and the company's ability to drive hospital adoption for its specialized device products.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as the community leans into its history as an original internet parody, positioning it as a cultural counter-narrative to traditional crypto assets. Discussions are dominated by debates over its long-term viability, with vocal supporters framing it as a multi-billion dollar opportunity while others dismiss the project as part of a wider trend of memetic absurdity.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is generating significant community buzz as investors debate its long-term transactional utility against Bitcoin, with many keeping a close watch on potential catalysts like institutional adoption and integration with major platforms. Traders are currently split between viewing the asset as a prime short-squeeze opportunity and maintaining a cautious stance amidst broader market volatility.

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita is seeing significant trading activity as investors react to concerns over the impact of GLP-1 weight-loss drugs on the long-term demand for dialysis services. While the market has reacted sharply to clinical trial news from the obesity drug sector, analysts and community participants are actively debating whether this sell-off represents an overreaction or a fundamental shift in the kidney care landscape.

Vanguard World Fund - Vanguard Emerging Markets Ex-China ETF

Investors are increasingly utilizing this ETF as a strategic alternative to gain exposure to emerging markets while intentionally avoiding Chinese equities. Market participants are actively debating the merits of geographical diversification in response to heightened geopolitical volatility and concerns regarding systemic stability in international markets.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating intense community interest due to its ultra-low circulating supply and potential for price appreciation within the NFT and DeFi sectors. Investors are actively discussing the possibility of a supply shock and a significant breakout, with many advocating for accumulation despite recent volatility and skepticism.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is facing increased volatility and investor scrutiny as shareholders navigate the impact of conservative forward revenue guidance and the upcoming transition in reimbursement for DefenCath. While the community remains divided over management's communication and strategy, discussion is heavily focused on potential legislative catalysts like the Kidney Care Access Protection Act and the anticipated readout of Phase 3 trial data for Rezzayo.

ARK 21Shares Bitcoin ETF - ARK 21Shares Bitcoin ETF Beneficial Interest

ARK 21Shares Bitcoin ETF

Investors are closely monitoring Bitcoin ETFs like ARKB, IBIT, and FBTC as sustained institutional demand and significant daily inflows continue to drive market sentiment despite recent price volatility. The broader community remains focused on the potential impact of the upcoming halving and the long-term role of Bitcoin as a strategic asset amidst ongoing macroeconomic shifts.

Rio Tinto Plc engages in the exploration, mining, and processing of mineral resources. It operates through the following business segments: Iron Ore, Aluminium, Copper, and Minerals. The Iron Ore segment supplies iron ore mining and salt and gypsum production. The Aluminium segment produces bauxite, alumina and primary aluminum. The Copper segment offers gold, silver, molybdenum and other by-products. The Minerals includes businesses with products such as uranium, borates, salt and titanium dioxide feedstock together with coal operations. The Other Operations segment covers the curtailed Gove alumina refinery and Rio Tinto Marine operations. The company was founded in 1873 and is headquartered in London, the United Kingdom.

Rio Tinto plc - ADR

Rio Tinto plc

Rio Tinto is trending as investors monitor ongoing copper supply chain developments, including the company's progress with Nuton bio-leaching technology and strategic production adjustments. The community remains focused on the company's role in the global energy transition, often debating its long-term commodity leverage compared to broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Longboard Pharmaceuticals surged over 50% pre-market Monday, pushing the stock into the top five most trending tickers on Stocktwits before the bell.Denmark-based H. Lundbeck A/S and Longboard announced a deal for Lundbeck to acquire Longboard.Under the agreement, Lundbeck will offer $60 per share in cash for all outstanding Longboard common stock, valuing the transaction at approximately $2.6 billion in equity and $2.5 billion net of cash.Lundbeck, known for its focus on serious brain diseases, sees this acquisition as a boost to its neuro-rare condition pipeline.Longboard’s lead asset, bexicaserin, a potential blockbuster drug for rare epilepsies, is expected to start Phase 3 testing by the end of 2024.The deal also brings Longboard’s LP659, an S1P modulator showing greater specificity than current S1P modulators in the market, to Lundbeck’s portfolio.LP659’s Phase 1 data has been described by some Wall Street analysts as “promising,” with potential for a better therapeutic window. S1P modulators are immunomodulatory drugs, commonly used in treating conditions like multiple sclerosis.“This transformative transaction will become a cornerstone in Lundbeck’s neuro-rare franchise, with a potential to drive growth into the next decade,” said Lundbeck CEO Charl van Zyl.The deal, expected to close in the fourth quarter of 2024, is contingent on regulatory approvals and the tendering of a majority of Longboard’s voting shares.Lundbeck said it plans to fund the acquisition with its existing cash and financing resources.<figure class="image"><a href="https://stocktwits.com/symbol/LBPH"><img style="aspect-ratio:1322/328;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/LBPH_sentiment_and_message_volume_Oct_14_2024_f3ba5d903e.png" alt="LBPH sentiment and message volume Oct 14 2024.png" width="1322" height="328"></a><figcaption>LBPH sentiment and message volume Oct 14 2024 premarket as of 9 am ET | source: Stocktwits</figcaption></figure>Retail sentiment for LBPH remains ‘bullish’ on Stocktwits, where the stock’s following has surged by over 340% in the past year, fueled by investor interest in bexicaserin, considered a competitor to Fintepla in the epilepsy market.<stembedurl>https://stocktwits.com/DannyTrejoTrades/message/588831537</stembedurl>LBPH shares have risen nearly 55% year to date as of the last close.Read next: <a href="https://stocktwits.com/news-articles/markets/equity/mstr-mara-riot-stocks-trend-on-bitcoin-jump/cJcMoyMR4O">Bitcoin Jump Boosts MicroStrategy, Marathon, Riot Stocks Pre-Market: Retail Flocks To Trending Tickers</a>

The deal, expected to close in the fourth quarter of 2024, is contingent on regulatory approvals and the tendering of a majority of Longboard’s voting shares.

Longboard Pharma Stock Surges Over 50% Pre-market, Gets Retail Attention On $2.6B Buyout Deal From Denmark’s Lundbeck

The acquisition will bolster Lundbeck’s pipeline in neuro-rare diseases with Longboard’s drug candidate to treat rare epilepsies

Equity

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.

LBPH
Longboard Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LBPH News

LBPHLongboard Pharmaceuticals Inc